Penetapan Kadar Senyawa Epikatekin dalam Ekstrak Air Kulit Batang Faloak (Sterculia quadrifida R.Br.) Berbagai Varian sebagai Antihepatitis C

Muhajirin Dean, Arley Sadra Telussa, Elric Brahm Malelak

Abstract


Background: East Nusa Tenggara Province, Indonesia, is a common location for the faloak plant. Due to its epicatechin compounds, the faloak plant (Sterculia quadrifida R.Br) has potential for use as an anti-hepatitis C treatment. Objective: This study aims to identify the highest epicatechin content of faloak obtained from various places, to optimize the cultivation and processing of faloak plants into herbal antihepatitis C medicines. General therapy for hepatitis C causes side effects such as hemolytic anemia, pruritus, asthenia, neutropenia, myalgia, respiratory problems, cardiovascular disorders, and even teratogenic. Methods: Faloak plants obtained from 3 locations (Rote, Timor, and Semau Islands) were extracted with water solvent. The extracts were then analyzed by HPLC to measure epicatechin levels using standard. Results: All three samples from different islands demonstrated the presence of epicatechin, as indicated by their retention times matching the standard compound. The retention times for the Faloak water extracts from Rote, Timor, and Semau Islands were 12.420, 12.427, and 12.353, respectively. The assay results revealed that the sample from Rote Island had the highest concentration, measuring 24.810%. Conclusion: All faloak water extracts contain epicatechin, with the highest concentration found in faloak from Rote Island.

Full Text:

PDF

References


  1. Siswadi, et al. Karakteristik Pertumbuhan Tanaman Faloak (Sterculia Quadrifida R.Br.) Asal Populasi Pulau Rote. Jurnal Penelitian Kehutanan Faloak. 2020; 4(2): 81-94. 10.20886/jpkf.2020.4.2.81-94.
  2. Hertiani, T., Purwantiningsih, Winanta, A., Sasikirana, W., Munawaroh, R., Setyowati, E. P., … Siswadi. In Vitro Immunomodulatory and Cytotoxic Potentials of Faloak (Sterculia quadrifida R.Br.) Bark. OnLine Journal of Biological Sciences. 2019; 19(4): 222–231. https://doi.org/10.3844/ojbsci.2019.222.231
  3. Dean M, Handajani R, Khotib J. Faloak (Sterculia quadrifida R.Br) Stem Bark Extract Inhibits Hepatitis C Virus JFH1. Oriental Journal of Chemistry. 2019; 35(1): 430-435. https://doi.org/10.13005/ojc/350155
  4. Bestari M B, Nugraha E S, Abdurachman S A. The Efficacy of Generic Daclatasvir-Sofosbuvir as Pan-Genotypic Regiment for Hepatitis C Virus (HCV) Infected Patients in Bandung Indonesia. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy. 2020; 21(1). 10.24871/21120207-11
  5. Sandmann L, Schulte B, Manns M P, Maasoumy B. Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications. Visceral medicine. 2019; 35(3): 161–170. https://doi.org/10.1159/000500963
  6. Zeng H, Li L, Hou Z, Zhang Y, Tang Z, Liu S. Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges. International journal of medical sciences. 2020; 17(7): 892–902. https://doi.org/10.7150/ijms.43079
  7. Geddawy A, Ibrahim Y F, Elbahie N M, Ibrahim M A. Direct Acting Antihepatitis C Virus Drugs: Clinical Pharmacology and Future Direction. Journal of translational internal medicine. 2017; 5(1): 8–17. https://doi.org/10.1515/jtim-2017-0007
  8. Sari D A, Sutarga I M. Karakteristik Penderita Hepatitis C di Provinsi Bali Tahun 2018 – 2019. Arc Com Health. 2021; 8(2): 204 – 215.
  9. Hayes K N, Burkard T, Weiler S, Tadrous M, Burden A M. Global Adverse Events Reported For Direct-Acting Antiviral Therapies For The Treatment Of Hepatitis C: an analysis of the World Health Organization VigiBase. European journal of gastroenterology & hepatology. 2021; 33. https://doi.org/10.1097/MEG.0000000000002173
  10. Song J M. Anti-infective Potential of Catechins a nd Their Derivatives Against Viral Hepatitis. Clinical and Experimental Vaccine Research. 2018; 7(1): 37–42. https://doi.org/10.7774/cevr.2018.7.1.37
  11. Skoog D A, Holler F J, Crouch S R. 2014. Principles of Instrumental Analysis (6th ed.). Cengage Learning
  12. Snyder L R, Kirkland J J, Dolan J W. 2010. Introduction to Modern Liquid Chromatography (3rd ed.). John Wiley & Sons.
  13. Astuti W Y, Respatie D W. Study of Secondary Metabolites Compounds in Cucumber (Cucumis sativus L.). Vegetalika. 2022; 11(2): 122-134. https://doi.org/10.22146/veg.60886
  14. Muslich, Utami S, Indrasti N S. Palm Oil Recovery Through Reflux Extraction from Spent Bleaching Earth. Jurnal Teknologi Industri Pertanian. 2020; 20(1): 90-99. https://doi.org/10.24961/j.tek.ind.pert.2020.30.1.90
  15. Darmanti S. Pengaruh Kumulatif Cekaman Biotik dan Abiotik Terhadap Penurunan Pertumbuhan Tajuk Tanaman Kedelai (Glycine max (L.) Merr.) cv. Grobogan. Buletin Anatomi dan Fisiologi. 2016; 1(1): 48 – 53.
  16. Toscano S A, Trivellini G, Cocetta R, Bulgari A, Francini D, Romano, Ferrante A. Effect Of Preharvest Abiotic Stresses On The Accumulation Of Bioactive Compounds In Horticultural Produce. Frontiers in Plant Science. 2019; 10(12): 1-17.
  17. Ruskim J, Budiono R, Kartini, Oktaviyanti N D, Setiawan F. Isolation based on antioxidant activity of 80% ethanolic extract faloak (Sterculia quadrifida R. Br.) stem bark. Scientific Journal of Pharmacy. 2023: 102-115.
  18. Amin A, Wunas J, Anin Y M. Uji Aktivitas Antioksidan Ekstrak Etanol Klika Faloak (Sterculia quadrifida R.Br) Dengan Metode DPPH (2,2-diphenyl-1-picrylhydrazyl). Jurnal Fitofarmaka Indonesia. 2015; 2(2): 111-114.
  19. Tenda P E, Kapitan L A V, Indrawati M I M, Soeharto F R. Quality and antioxidant activity of faloak (Sterculia quardifida R.Br.) extract syrup with variations in addition to ginger (Zingiber officinale R.). Scientific Journal of Pharmacy. 2023; 19(1): 15-30.
  20. Dewajanthi A M, Sentosa F C V, Rumiati F, Winata H. Efektivitas Antioksidan Tanaman Faloak (Sterculia quadrifida). Jurnal MedScientiae. 2022; 1(2): 82-90. https://doi.org/10.36452/jmedscientiae.v1i2.2643
  21. Tenda P E, Lenggu M Y, Ngale M S. Uji Aktivitas Antibakteri Ekstrak Etanol Kulit Pohon Faloak (Sterculia sp.) Terhadap Bakteri Staphylococcus Aureus. Jurnal Info Kesehatan. 2017; 15(1): 227-239. https://doi.org.10.31965/infokes.v15i1.143




DOI: https://doi.org/10.18860/jim.v8i2.28895

Refbacks

  • There are currently no refbacks.


 

Editorial Office:

Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 8563588384, Faximile (+62) 341 558933
e-mail: medicaljournal@uin-malang.ac.id

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.